Literature DB >> 27465141

Identification of differentially regulated genes in human patent ductus arteriosus.

Pratik Parikh1, Haiqing Bai1, Michael F Swartz2, George M Alfieris1,2, David A Dean1,3.   

Abstract

In order to identify differentially expressed genes that are specific to the ductus arteriosus, 18 candidate genes were evaluated in matched ductus arteriosus and aortic samples from infants with coarctation of the aorta. The cell specificity of the gene's promoters was assessed by performing transient transfection studies in primary cells derived from several patients. Segments of ductus arteriosus and aorta were isolated from infants requiring repair for coarctation of the aorta and used for mRNA quantitation and culturing of cells. Differences in expression were determined by quantitative PCR using the ΔΔCt method. Promoter regions of six of these genes were cloned into luciferase reporter plasmids for transient transfection studies in matched human ductus arteriosus and aorta cells. Transcription factor AP-2b and phospholipase A2 were significantly up-regulated in ductus arteriosus compared to aorta in whole tissues and cultured cells, respectively. In transient transfection experiments, Angiotensin II type 1 receptor and Prostaglandin E receptor 4 promoters consistently gave higher expression in matched ductus arteriosus versus aorta cells from multiple patients. Taken together, these results demonstrate that several genes are differentially expressed in ductus arteriosus and that their promoters may be used to drive ductus arteriosus-enriched transgene expression.

Entities:  

Keywords:  Neonatology; cardiovascular; gene; gene therapy; heart; pediatric

Mesh:

Substances:

Year:  2016        PMID: 27465141      PMCID: PMC5102136          DOI: 10.1177/1535370216661778

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  30 in total

Review 1.  Genetics of patent ductus arteriosus susceptibility and treatment.

Authors:  Hanine Hajj; John M Dagle
Journal:  Semin Perinatol       Date:  2012-04       Impact factor: 3.300

2.  DNA microarray profiling identified a new role of growth hormone in vascular remodeling of rat ductus arteriosus.

Authors:  Mei-Hua Jin; Utako Yokoyama; Yoji Sato; Aki Shioda; Qibin Jiao; Yoshihiro Ishikawa; Susumu Minamisawa
Journal:  J Physiol Sci       Date:  2011-02-02       Impact factor: 2.781

3.  Factors that increase the contractile tone of the ductus arteriosus also regulate its anatomic remodeling.

Authors:  H Kajino; Y Q Chen; S R Seidner; N Waleh; F Mauray; C Roman; S Chemtob; C J Koch; R I Clyman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-07       Impact factor: 3.619

Review 4.  Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn.

Authors:  Batoule H Majed; Raouf A Khalil
Journal:  Pharmacol Rev       Date:  2012-06-07       Impact factor: 25.468

5.  Single nucleotide polymorphisms in AGTR1, TFAP2B, and TRAF1 are not associated with the incidence of patent ductus arteriosus in Japanese preterm infants.

Authors:  Koya Kawase; Tokio Sugiura; Yoshiaki Nagaya; Takaharu Yamada; Mari Sugimoto; Koichi Ito; Takao Togawa; Rika Nagasaki; Takenori Kato; Masanori Kouwaki; Norihisa Koyama; Shinji Saitoh
Journal:  Pediatr Int       Date:  2016-02-03       Impact factor: 1.524

6.  Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.

Authors:  Nahid Waleh; Anne Marie Barrette; John M Dagle; Allison Momany; Chengshi Jin; Nancy K Hills; Elaine L Shelton; Jeff Reese; Ronald I Clyman
Journal:  J Pediatr       Date:  2015-08-08       Impact factor: 4.406

7.  Failure of ductus arteriosus closure is associated with increased mortality in preterm infants.

Authors:  Shahab Noori; Michael McCoy; Philippe Friedlich; Brianna Bright; Venugopal Gottipati; Istvan Seri; Kris Sekar
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

8.  Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice.

Authors:  Jianhe Huang; Lan Cheng; Jian Li; Mary Chen; Deying Zhou; Min Min Lu; Aaron Proweller; Jonathan A Epstein; Michael S Parmacek
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Angiotensin II type 1 receptor A1166C polymorphism and prophylactic indomethacin treatment induced ductus arteriosus closure in very low birth weight neonates.

Authors:  Andras Treszl; Miklos Szabo; Gyorgy Dunai; Andras Nobilis; Istvan Kocsis; Tamas Machay; Tivadar Tulassay; Barna Vasarhelyi
Journal:  Pediatr Res       Date:  2003-08-06       Impact factor: 3.756

10.  A subpopulation of smooth muscle cells, derived from melanocyte-competent precursors, prevents patent ductus arteriosus.

Authors:  Ichiro Yajima; Sophie Colombo; Isabel Puig; Delphine Champeval; Mayuko Kumasaka; Elodie Belloir; Jacky Bonaventure; Manuel Mark; Hiroaki Yamamoto; Mark M Taketo; Philippe Choquet; Heather C Etchevers; Friedrich Beermann; Véronique Delmas; Laurent Monassier; Lionel Larue
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more
  3 in total

Review 1.  Novel drug targets for ductus arteriosus manipulation: Looking beyond prostaglandins.

Authors:  Elaine L Shelton; Gautam K Singh; Colin G Nichols
Journal:  Semin Perinatol       Date:  2018-05-10       Impact factor: 3.300

2.  Dark-colored maple syrup treatment induces S-phase cell cycle arrest via reduced proliferating cell nuclear antigen expression in colorectal cancer cells.

Authors:  Tetsushi Yamamoto; Tomoyo Nishita; Atsushi Taga
Journal:  Oncol Lett       Date:  2019-01-14       Impact factor: 2.967

3.  Transcriptional profiles in the chicken ductus arteriosus during hatching.

Authors:  Toru Akaike; Satoko Shinjo; Eriko Ohmori; Ichige Kajimura; Nobuhito Goda; Susumu Minamisawa
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.